These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1925896)

  • 21. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
    Ragaz J; Olivotto IA; Spinelli JJ; Phillips N; Jackson SM; Wilson KS; Knowling MA; Coppin CM; Weir L; Gelmon K; Le N; Durand R; Coldman AJ; Manji M
    J Natl Cancer Inst; 2005 Jan; 97(2):116-26. PubMed ID: 15657341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant treatment for early breast cancer: the Ludwig breast cancer studies.
    Goldhirsch A; Gelber R
    NCI Monogr; 1986; (1):55-70. PubMed ID: 3774016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of long-term survivors in primary breast cancer by dynamic modelling of tumour response.
    Cameron DA; Gregory WM; Bowman A; Anderson ED; Levack P; Forouhi P; Leonard RC
    Br J Cancer; 2000 Jul; 83(1):98-103. PubMed ID: 10883676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive value of estrogen receptor status as assessed by ligand-binding assay in patients with early-stage breast cancer treated with breast conserving surgery and radiation therapy.
    Takei H; Horiguchi J; Maemura M; Koibuchi Y; Oyama T; Yokoe T; Iino Y; Morishita Y
    Oncol Rep; 2002; 9(2):375-8. PubMed ID: 11836611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer.
    Generali D; Berruti A; Brizzi MP; Campo L; Bonardi S; Wigfield S; Bersiga A; Allevi G; Milani M; Aguggini S; Gandolfi V; Dogliotti L; Bottini A; Harris AL; Fox SB
    Clin Cancer Res; 2006 Aug; 12(15):4562-8. PubMed ID: 16899602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormone receptor status and mitotic activity as risk factors for recurrence and death in female breast carcinoma.
    Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
    Anticancer Res; 1991; 11(5):1701-6. PubMed ID: 1768039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Demonstration of the effect of estrogen and progesterone receptors on survival in breast cancer without cytostatic and hormonal treatment in a small set of patients].
    Hochmann J
    Klin Onkol; 2010; 23(1):25-33. PubMed ID: 20192071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The role of tumor receptor status in choosing adjuvant therapy for breast cancer patients of reproductive age].
    Samgina AA; Letiagin VP; Kuz'mina ZV
    Vopr Onkol; 1992; 38(7):780-7. PubMed ID: 1300782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An evaluation of the prognostic significance of HLA-DR expression in axillary-node-negative breast cancer.
    Sheen-Chen SM; Chou FF; Eng HL; Chen WJ
    Surgery; 1994 Sep; 116(3):510-5. PubMed ID: 8079182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphologic and clinical aspects of estrogen receptors in carcinoma of the breast.
    Kern WH
    Surg Gynecol Obstet; 1979 Feb; 148(2):240-2. PubMed ID: 217114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ER, HER2, and TOP2A expression in primary tumor, synchronous axillary nodes, and asynchronous metastases in breast cancer.
    Jensen JD; Knoop A; Ewertz M; Laenkholm AV
    Breast Cancer Res Treat; 2012 Apr; 132(2):511-21. PubMed ID: 21667123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inflammatory cancer of the breast. Therapy and follow-up].
    Volz J; Volz E; Böhm W; Schneider V
    Geburtshilfe Frauenheilkd; 1992 Apr; 52(4):206-9. PubMed ID: 1607113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Axillary micrometastasis and macrometastasis in carcinoma of the breast.
    Attiyeh FF; Jensen M; Huvos AG; Fracchia A
    Surg Gynecol Obstet; 1977 Jun; 144(6):839-42. PubMed ID: 860185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A ten year study of medullary carcinoma of the breast.
    Maier WP; Rosemond GP; Goldman LI; Kaplan GF; Tyson RR
    Surg Gynecol Obstet; 1977 May; 144(5):695-8. PubMed ID: 850851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen receptor assay in primary breast cancer and early recurrence of the disease.
    Maynard PV; Blamey RW; Elston CW; Haybittle JL; Griffiths K
    Cancer Res; 1978 Nov; 38(11 Pt 2):4292-5. PubMed ID: 698968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thymidine labeling index and estrogen receptor level in 64 human breast cancers.
    Gioanni J; Farges MF; Lalanne CM; Francoual M; Namer M
    Biomedicine; 1979 Dec; 31(8):239-43. PubMed ID: 534681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between 43 kDa epidermal growth factor-related clonogenic activity and clinical parameters for breast cancer.
    Eckert K; Granetzny A; Fischer J; Grosse R
    Anticancer Res; 1991; 11(6):2125-30. PubMed ID: 1776851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer.
    Lippman ME; Allegra JC; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC; Warren R
    N Engl J Med; 1978 Jun; 298(22):1223-8. PubMed ID: 651963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The correlation between estrogen receptor status, axillary-node metastases and disease-free interval after surgery in primary breast cancer.
    Caldarola L; Calderini P; Volterrani P; Di Carlo F; Gaglia P
    Ital J Surg Sci; 1983; 13(3):179-85. PubMed ID: 6643007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.